[1] Rudd K E,Johnson S C,Agesa K M,et al.Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study[J].Lancet,2020,395(10219):200-211.
[2] Perez-Castells J,Martin-Santamaria S,Nieto L,et al.Structure of micelle-bound adrenomedullin: a first step toward the analysis of its interactions with receptors and small molecules[J].Biopolymers,2012,97(1):45-53.
[3] van Lier D,Kox M,Pickkers P.Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3[J].J Intern Med,2021,289(6):792-806.
[4] Martinez H S, Martinez A A.Adrenomedullin:not just another gastrointestinal peptide[J]. Biomolecules,2022,12(2):156.
[5] Kitamura K,Kangawa K,Kawamoto M,et al.Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma[J].Biochem Biophys Res Commun,2012,425(3):548-555.
[6] Schonauer R,Kaiser A,Holze C,et al.Fluorescently labeled adrenomedullin allows real-time monitoring of adrenomedullin receptor trafficking in living cells[J].J Pept Sci,2015,21(12):905-912.
[7] Larrayoz I M,Martinez-Herrero S,Garcia-Sanmartin J,et al.Adrenomedullin and tumour microenvironment[J].J Transl Med,2014,12:339.
[8] Garayoa M,Martinez A,Lee S,et al.Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis[J].Mol Endocrinol,2000,14(6):848-862.
[9] Lewis L K,Smith M W,Brennan S O,et al.Degradation of human adrenomedullin(1-52) by plasma membrane enzymes and identification of metabolites[J].Peptides,1997,18(5):733-739.
[10] Kuwasako K,Kitamura K,Nagata S,et al.Shared and separate functions of the RAMP-based adrenomedullin receptors[J].Peptides,2011,32(7):1540-1550.
[11] Geven C,Kox M,Pickkers P.Adrenomedullin and adrenomedullin-targeted therapy as treatment strategies relevant for sepsis[J].Front Immunol,2018,9:292.
[12] Passaglia P,Gonzaga N A,Tirapelli D P,et al.Pharmacological characterisation of the mechanisms underlying the relaxant effect of adrenomedullin in the rat carotid artery[J].J Pharm Pharmacol,2014,66(12):1734-1746.
[13] Bell D,Campbell M,Mcaleer S F,et al.Endothelium-derived intermedin/adrenomedullin-2 protects human ventricular cardiomyocytes from ischaemia-reoxygenation injury predominantly via the AM(1) receptor[J].Peptides,2016,76:1-13.
[14] Rulle S,Kioon M D,Asensio C,et al.Adrenomedullin, a neuropeptide with immunoregulatory properties induces semi-mature tolerogenic dendritic cells[J].Immunology,2012,136(2):252-264.
[15] Schonauer R,Els-Heindl S,Beck-Sickinger AG.Adrenomedullin-new perspectives of a potent peptide hormone[J].J Pept Sci,2017,23(7-8):472-485.
[16] Mohebbi A,Haybar H,Nakhaei M F,et al. Biomarkers of endothelial dysfunction are associated with poor outcome in COVID-19 patients: a systematic review and meta-analysis[J].Rev Med Virol,2023,33(4):e2442.
[17] Kita T,Suzuki Y,Kitamura K.Hemodynamic and hormonal effects of exogenous adrenomedullin administration in humans and relationship to insulin resistance[J].Hypertens Res,2010,33(4):314-319.
[18] Koyama T,Ochoa C L,Sakurai T,et al.Vascular endothelial adrenomedullin-RAMP2 system is essential for vascular integrity and organ homeostasis[J].Circulation,2013,127(7):842-853.
[19] Shindo T,Kurihara Y,Nishimatsu H,et al.Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene[J].Circulation,2001,104(16):1964-1971.
[20] Henry A,Gordillo M M,Finan C,et al.Therapeutic targets for heart failure identified using proteomics and mendelian randomization[J].Circulation,2022,145(16):1205-1217.
[21] Ochoa C L,Pozo R A,Martinez M R,et al.Lack of adrenomedullin in mouse endothelial cells results in defective angiogenesis, enhanced vascular permeability, less metastasis, and more brain damage[J].Sci Rep,2016,6:33495.
[22] Ince C,Mayeux P R,Nguyen T,et al.The endothelium in sepsis[J].Shock,2016,45(3):259-270.
[23] Deutschman C S,Tracey K J.Sepsis: current dogma and new perspectives[J].Immunity,2014,40(4):463-475.
[24] Tolppanen H,Rivas L M,Lassus J,et al.Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock[J].Ann Intensive Care,2017,7(1):6.
[25] Mebazaa A,Geven C,Hollinger A,et al.Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational adrenomedullin and outcome in sepsis and septic shock-1 (AdrenOSS-1) study[J].Crit Care,2018,22(1):354.
[26] Lundberg O H,Lengquist M,Spangfors M,et al.Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness[J].Crit Care,2020,24(1):636.
[27] Liang J,Cai Y,Shao Y.Comparison of presepsin and Mid-regional pro-adrenomedullin in the diagnosis of sepsis or septic shock: a systematic review and meta-analysis[J].BMC Infect Dis,2023,23(1):288.
[28] Dou Y H,Du J K,Liu H L,et al.The role of procalcitonin in the identification of invasive fungal infection-a systemic review and meta-analysis[J].Diagn Microbiol Infect Dis,2013,76(4):464-469.
[29] Angeletti S,Battistoni F,Fioravanti M,et al.Procalcitonin and mid-regional pro-adrenomedullin test combination in sepsis diagnosis[J].Clin Chem Lab Med,2013,51(5):1059-1067.
[30] Charles P E,Peju E,Dantec A,et al.Mr-proadm elevation upon icu admission predicts the outcome of septic patients and is correlated with upcoming fluid overload[J].Shock,2017,48(4):418-426.
[31] Spoto S,Basili S,Cangemi R,et al.Mid-Regional pro-adrenomedullin can predict organ failure and prognosis in sepsis?[J].Int J Mol Sci,2023,24(24):78-82.
[32] Lundberg O H M,Rosenqvist M,Bronton K,et al.Melander O. Bioactive adrenomedullin in sepsis patients in the emergency department is associated with mortality, organ failure and admission to intensive care[J].PLoS One,2022,17(4):e0267497.
[33] Kox M,Pickkers P.Adrenomedullin: its double-edged sword during sepsis slices yet again[J].Intensive Care Med Exp,2014,2(1):1.
[34] Temmesfeld-Wollbruck B,Brell B,David I,et al.Adrenomedullin reduces vascular hyperpermeability and improves survival in rat septic shock[J].Intensive Care Med,2007,33(4):703-710.
[35] Wollbruck B,Brell B, Dohna C,et al.Adrenomedullin reduces intestinal epithelial permeability in vivo and in vitro[J].Am J Physiol Gastrointest Liver Physiol,2009,297(1):G43-51.
[36] Redetzky H C,Will D,Hellwig K,et al.Mechanical ventilation drives pneumococcal pneumonia into lung injury and sepsis in mice: protection by adrenomedullin[J].Crit Care,2014,18(2):R73.
[37] Laterre P F,Pickkers P,Marx G,et al.Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial[J].Intensive Care Med,2021,47(11):1284-1294.
[38] Karakas M,Akin I,Burdelski C,et al.Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial[J].Lancet Respir Med,2022,10(3):247-254.
[39] Hupf J,Mustroph J,Hanses F,et al.RNA-expression of adrenomedullin is increased in patients with severe COVID-19[J].Crit Care,2020,24(1):527.
[40] Guadiana R L,Calvo N M,Rodriguez M D,et al.MR-proADM as marker of endotheliitis predicts COVID-19 severity[J].Eur J Clin Invest,2021,51(5):e13511.
[41] Minieri M,Lecce V N,Lia M S,et al.Role of MR-proADM in the risk stratification of COVID-19 patients assessed at the triage of the emergency department[J].Crit Care,2021,25(1):407.
[42] Gregoriano C,Koch D,Kutz A,et al.The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study[J].Clin Chem Lab Med,2021,59(5):995-1004.
[43] Mangioni D,Oggioni M,Chatenoud L,et al.Prognostic value of mid-region proadrenomedullin and in vitro interferon gamma production for in-hospital mortality in patients with COVID-19 pneumonia and respiratory failure: an observational prospective study[J].Viruses,2022,14(8):56-60.
[44] Papasidero I D,Valli G,Marin D,et al.Utility of measuring circulating bio-adrenomedullin and proenkephalin for 30-day mortality risk prediction in patients with COVID-19 and Non-COVID-19 interstitial pneumonia in the emergency department[J].Medicina,2022,58(12):78-80.
[45] Astapovskii A A,Drozdov V N,Shikh E V,et al.Prognostic value of proadrenomedullin in patients with COVID-19 pneumonia[J].Front Med,2022,9:961071.